Back to search

Article

Gaboxadol Increases Resting Theta and Alpha Power without Affecting Evoked Responses in Fragile X Syndrome in a Home-based Setting

2025-10-24

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Fragile X syndrome (FXS) lacks FDA-approved treatments despite various small molecules contributing to phenotypic rescue in the <italic>FMR1</italic> knockout (KO) mouse model. Translation from the mouse model has been hampered by phenotypic heterogeneity that contributes to participation barriers among participants who are most affected and may be unable t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
42a49d13-6f45-58ec-8792-27b617370ca3
DOI
10.21203/rs.3.rs-7871579/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Gaboxadol Increases Resting Theta and Alpha Power without Affecting Evoked Responses in Fragile X Syndrome in a Home-based SettingDOI 10.21203/rs.3.rs-7871579/v1
Select a neighboring publication to make it the new centre.